Fig 1.
Mice were tested in a behavioral test battery consisting of (top panel, from left to right): forced alternation (Y-maze), novel object recognition, Morris water maze, radial arm water maze, and spontaneous alternation (Y-maze) over a period of 8 weeks. Top panel: Behavioral tests conducted in the study. Middle panel: Timeline of tests. Bottom panel: Trials conducted per behavioral test. Tests were conducted in the order of increasing invasiveness. The spontaneous alternation test was performed last to maximize the interval to the forced alternation test, which utilized the same maze.
Table 1.
A) Locomotor activity for control and scopolamine-treated mice, B) locomotor activity for WT and Tg2576 mice. Values are mean ± SEM; Student’s t-test was used to calculate p values.
Fig 2.
A) Scopolamine-HBr (10 mg/kg) or saline was administered by i.p. injection 30 min before the sample trial. A retrieval trial was conducted 30 min after the sample trial. The time spent in the novel arm during the first minute of the retrieval trial was analyzed. For both treatment groups (saline control: Ctrl; scopolamine: SCP), time spent in the novel arm was about 33%, with no statistically significant difference between groups (n = 9/group). B) In the second arm entry of the retrieval trial, saline-injected control mice entered the novel arm less often than scopolamine-treated mice (SCP). C) 129S6/Tg2576 mice (11–13 months) spent significantly less time in the novel arm during the retrieval trial and D) entered significantly less often into the novel arm (n = 19-20/group). The control has no error bar because all mice (100%) first went into the novel arm. Mice with less than 3 arm entries in the first minute were excluded from the analysis. Data are mean ± SEM; **p < 0.01; ***p < 0.001 (Student’s t-test for Fig 2A and 2C; Chi-squared test for Fig 2B and 2D).
Fig 3.
A) Both control (Ctrl) and scopolamine-treated (SCP) mice showed no preference for the novel object over the familiar object (n = 8-9/group), but control mice showed a trend to interact more with the novel object (p = 0.466). B) Tg2576 mice showed a trend to interact less with the novel object (p = 0.257; n = 18-19/group). Mice with less than 7 sec of object interaction in either trial were excluded from the analysis. Data are mean ± SEM; Student’s t-test was used to calculate p values.
Fig 4.
Morris Water Maze: Cued Learning and Spatial Acquisition.
A) In the first four days of the cued learning trial, the latency time to locate the visible platform was significantly longer for scopolamine-treated mice (SCP) compared to untreated control mice (Ctrl; n = 10/group). (B) The latency of scopolamine-treated mice was significantly longer compared to control mice in the spatial acquisition trials. C) Compared to WT mice, transgenic 129S6/Tg2576 mice had consistently higher latency times to find the tagged platform in the cued learning phase (n = 18-19/group). D) The latency time to find the hidden platform was higher for 129S6/Tg2576 mice than for WT mice, but this effect was only statistically significant for days 8, 9, 11, 12 and 13. Mice that showed repeated episodes of extensive floating (> 10 s/trial; > 25% of trials) were excluded from the analysis of the entire experiment. Data are mean ± SEM; *p < 0.05; **p < 0.01; **p < 0.001 (repeated measures ANOVA).
Fig 5.
Morris Water Maze: Retention of Spatial Reference Memory.
A) Compared to control mice (Ctrl), scopolamine-treated mice (SCP) spent less time in the target quadrant during the retention trial on days 14 and 17 and B) in the 40 cm annulus around the platform center on day 14 (n = 10/group). C) The group occupancy plot from the last retention trial (day 17) shows a similar search pattern for both groups. Red and yellow regions represent areas of high occupancy; green and blue represent areas of low occupancy. D) On days 14 and 17 of the retention trials, 129S6/Tg2576 mice spent less time in the target quadrant compared to WT control mice (statistically not significant). E) 129S6/Tg2576 mice spent significantly less time in the 40 cm platform annulus compared to age-matched WT control mice (n = 18-19/group) on days 14 and 17 of the retention trials. F) Occupancy plots obtained from WT and transgenic mice in the last retention trial (day 17) exhibited a similar search pattern for both groups. Mice that showed repeated episodes of extensive floating (> 10 s/trial; >25% of trials) were excluded from analysis for the entire experiment. Data are mean ± SEM; *p < 0.05; **p < 0.01 (Student’s t-test).
Fig 6.
A) Scopolamine-treated mice (SCP) made more errors at learning (trials 1–4) and remembering (trial 5) the hidden platform location than control mice (Ctrl) did (n = 9-10/group). B) Long-term (24 h) memory of mice was evaluated by averaging the entries into the previous target arm during the first trial of days 2–12. SCP mice entered into the last target arm significantly less than control mice. C) 129S6/Tg2576 mice made significantly more errors during the learning phase (trials 1–4) of the radial arm water maze test compared to WT control mice. D) The number of entries into the last target arm were not different between 129S6/Tg2576 mice and WT control mice (n = 19-20/group). Data are mean ± SEM; 6A and 6C: *p < 0.05; **p < 0.01; ***p < 0.001 (repeated measures ANOVA); 6B and 6D: ***p < 0.001 (repeated measures ANOVA was used for Fig 6A and 6C; Student’s t-test was used to calculated p values for Fig 6B and 6D).
Fig 7.
Spontaneous Alternation (Y-Maze).
A) Scopolamine-injected mice (SCP) and control (Ctrl) mice showed the same level of spontaneous alternation (n = 9-10/group). B) Scopolamine-treated mice had significantly more arm entries than control mice. C) 129S6/Tg2576 mice and WT mice performed showed the same level of spontaneous alternation (n = 16-19/group). D) The number of total arm entries between WT and 129S6/Tg2576 mice was not statistically different. Mice with less than 8 arm entries were excluded from the alternation analysis. Data are mean ± SEM; **p < 0.01 (Student’s t-test).